Hepato-Pancreatico-Biliary Cancer Symposium 2021

Memo

Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-pancreatico-biliary cancers. The program is designed to provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. There will be an emphasis on implementation of these approaches into clinical practice. Virtual, livestream option available at ce.mayo.edu/cancermgmt2021 Upon completion of this activity, participants should be able to: -Identify current and emerging strategies for early diagnosis and surveillance of liver cancer-Identify patients suitable for a liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches-Integrate novel molecularly-targeted, as well as immune-based, therapeutic strategies in clinical care and clinical trial participation-Describe molecular biology of pancreatic, liver and biliary cancers-Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer, liver and biliary cancer-Describe the latest state of the science in pancreatic cancer, liver and biliary cancer   Date and Time: On Fri, Nov 12, 2021 (8:00 AM) - Sat, Nov 13, 2021 (12:00 PM) Venue details: Wynn Las Vegas, 3131 South Las Vegas Boulevard, Las Vegas, Nevada, 89109, United States